Lack of socio-demographic participant diversity in endometriosis evidence risks unrepresentative clinical guidance: a structured review of a NICE guideline

Other OA: closed public-domain-us
⚙ AI-generated summary by qwen3.7-flash+body, 2026-09-04 ⓘ

A structured review of a NICE guideline reveals that lack of socio-demographic diversity in endometriosis evidence risks unrepresentative clinical guidance, particularly given the diagnostic challenges and care pathway complexities in primary care.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-04 · read from full text ⓘ

This structured review critiques the lack of socio-demographic diversity in the evidence base informing NICE guidelines for endometriosis, highlighting risks to clinical guidance representativeness. The authors note that diagnosis often involves complex referrals from primary to secondary care, where patients may not reflect the broader undifferentiated population initially presenting with symptoms. A significant limitation identified is the absence of specific NHS care pathways for longitudinal management between primary and secondary care settings despite the condition's chronic nature. This paper is centrally about endometriosis — specifically addressing gaps in diagnostic pathways and guideline development based on unrepresentative evidence.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 2,547 characters · extracted from oa-doi-fallback · click to expand
Introduction Endometriosis is a long-term condition affecting up to 10% of people assigned female at birth.1 Those affected can experience significant psychosocial and economic burdens.2,3 Diagnosis can be challenging: patients typically present to primary care with undifferentiated heterogeneous symptoms. Initial differential diagnoses to consider encompass a broad range of both gynaecological and non-gynaecological (for example, bladder or bowel) conditions that might warrant investigation. Primary care is often cited as a bottleneck in the diagnostic pathway for patients with endometriosis. However, this fails to recognise the complexity of patient needs in primary care and the lack of specific clinical evidence and guidance from and for this setting. It also fails to recognise the complex processes of referrals to secondary care, including advice and guidance services, and referral triage.4 The ‘gold standard’ diagnostic test for endometriosis has been laparoscopy.5 Diagnosis necessitates referral to secondary care for assessment, potentially followed by an empirical trial of medical therapy before, or in parallel with, referral for specialist tests, such as MRI or laparoscopy, culminating in long and sometimes fraught patient journeys.6 Patients referred to secondary care likely have an inherently raised pre-test probability of endometriosis, and may not reflect the undifferentiated patient population presenting to primary care with possible endometriosis symptoms such as dysmenorrhoea or pelvic pain. Following laparoscopy, patients diagnosed with endometriosis are often discharged back to primary care. Of these, 75% require subsequent re-referral(s) from general practice back to secondary care for further specialist input and guidance on ongoing management.7 There are no NHS care pathways for endometriosis pre- and post-diagnosis and between primary and secondary care, despite its recognition as a chronic condition requiring longitudinal care, as recently highlighted as a recommendation in the National Confidential Enquiry into Patient Outcome and Death (NCEPOD) report on … RCGP login Members, please Login at RCGP to access the journal online Subscriber login Enter your BJGP login information below. Log in using your username and password Log in through your institution Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00 Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (14)

Source provenance

europepmc
last seen: 2026-10-15T06:08:49.021275+00:00
openalex
last seen: 2026-10-15T06:00:39.803327+00:00
pubmed
last seen: 2026-10-15T06:02:21.945644+00:00
unpaywall
last seen: 2026-10-14T06:23:58.021457+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine